Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
IDXG Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: July 31, 2024
Report Source: 2024 1st Quarter Report
Interpace Biosciences Inc. Stock Analysis IDXG
United States Health Care Nano Cap Report: Interpace Biosciences, Inc. engages in the development and sale of diagnostic clinical and pharma services. The company is headquartered in Parsippany, New Jersey and currently employs 102 full-time employees. The Company’s clinical services business commercializes clinically useful molecular diagnostic tests and molecular pathology services. The firm develops and commercializes genomic tests and related first-line assays that can personalize medicine to help improve patient diagnosis and management. The company has five commercialized molecular diagnostic tests: PancraGEN, PanDNA, ThyGeNEXT, ThyraMIR v2, and RespriDX. PancraGEN is a pancreatic cyst and pancreaticobiliary solid lesion genomic test that helps physicians’ better risk-stratify pancreaticobiliary cancers using the Company’s proprietary PathFinderTG platform. PanDNA is an alternate reporting option of the PathFinderTG platform, which provides physicians the molecular only information. ThyGeNEXT is an oncogenic mutation panel that helps rule-in and rule-out malignancy in thyroid nodules.
Read More Interpace Biosciences Inc (IDXG) Chart
Key Statistics of Interpace Biosciences Inc (IDXG)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$1.63Volume
230.00P/E Ratio (TTM)
1.8952 Week Range
Market Cap
49.86MAvg. Volume
5131.32Dividend Yield
-Financial Metrics & Statements of Interpace Biosciences Inc (IDXG)
FAQ's for Interpace Biosciences Inc (IDXG)
- According to Musaffa’s Shariah screening methodology, Interpace Biosciences Inc (IDXG) is currently classified as NOT HALAL as of July 2024. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Interpace Biosciences Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Interpace Biosciences Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Interpace Biosciences Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Interpace Biosciences Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Interpace Biosciences Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.